Literature DB >> 35795620

Ursodeoxycholic Acid Decreases Incidence of Primary Biliary Cholangitis and Biliary Complications After Liver Transplantation.

Mariana C Zapata1, Mark R Pedersen1.   

Abstract

Content available: Audio Recording.
© 2021 by the American Association for the Study of Liver Diseases.

Entities:  

Year:  2022        PMID： 35795620      PMCID： PMC9248927          DOI： 10.1002/cld.1192

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


  6 in total

Review 1.  Efficacy of ursodeoxycholic acid as an adjuvant treatment to prevent acute cellular rejection after liver transplantation: a meta-analysis of randomized controlled trials.

Authors:  Yi-Lei Deng; Xian-Ze Xiong; Nan-Sheng Cheng
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2014-10

2.  Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis.

Authors:  Christophe Corpechot; Olivier Chazouillères; Pierre Belnou; Aldo J Montano-Loza; Andrew Mason; Maryam Ebadi; Dennis Eurich; Sascha Chopra; Dietmar Jacob; Christoph Schramm; Martina Sterneck; Tony Bruns; Philipp Reuken; Falk Rauchfuss; Davide Roccarina; Douglas Thorburn; Alessio Gerussi; Palak Trivedi; Gideon Hirschfield; Patrick McDowell; Frederik Nevens; Olivier Boillot; Alexie Bosch; Emiliano Giostra; Filomena Conti; Raoul Poupon; Albert Parés; Anna Reig; Maria Francesca Donato; Federica Malinverno; Annarosa Floreani; Francesco Paolo Russo; Nora Cazzagon; Xavier Verhelst; Jorn Goet; Maren Harms; Henk van Buuren; Bettina Hansen; Fabrice Carrat; Jérôme Dumortier
Journal:  J Hepatol       Date:  2020-04-07       Impact factor: 25.083

3.  Ursodeoxycholic Acid Decreases Incidence of Primary Biliary Cholangitis and Biliary Complications After Liver Transplantation: A Meta-Analysis.

Authors:  Mark R Pedersen; Garrett Greenan; Sumant Arora; Arvind R Murali; Marlyn J Mayo
Journal:  Liver Transpl       Date:  2021-06       Impact factor: 5.799

4.  Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis.

Authors:  Maren H Harms; Henk R van Buuren; Christophe Corpechot; Douglas Thorburn; Harry L A Janssen; Keith D Lindor; Gideon M Hirschfield; Albert Parés; Annarosa Floreani; Marlyn J Mayo; Pietro Invernizzi; Pier Maria Battezzati; Frederik Nevens; Cyriel Y Ponsioen; Andrew L Mason; Kris V Kowdley; Willem J Lammers; Bettina E Hansen; Adriaan J van der Meer
Journal:  J Hepatol       Date:  2019-04-11       Impact factor: 25.083

5.  Factors Associated With Recurrence of Primary Biliary Cholangitis After Liver Transplantation and Effects on Graft and Patient Survival.

Authors:  Aldo J Montano-Loza; Bettina E Hansen; Christophe Corpechot; Davide Roccarina; Douglas Thorburn; Palak Trivedi; Gideon Hirschfield; Patrick McDowell; Raoul Poupon; Jerome Dumortier; Alexie Bosch; Emiliano Giostria; Filomena Conti; Albert Parés; Anna Reig; Annarosa Floreani; Francesco Paolo Russo; Jorn C Goet; Maren H Harms; Henk van Buuren; Natalie Van den Ende; Frederik Nevens; Xavier Verhelst; Maria Francesca Donato; Federica Malinverno; Maryam Ebadi; Andrew L Mason
Journal:  Gastroenterology       Date:  2018-10-06       Impact factor: 22.682

Review 6.  A Review on the Management of Biliary Complications after Orthotopic Liver Transplantation.

Authors:  Brian T Moy; John W Birk
Journal:  J Clin Transl Hepatol       Date:  2018-12-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.